Silence Therapeutics PLC
F:XRP2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Silence Therapeutics PLC
F:XRP2
|
UK |
|
Fluidra SA
OTC:FLUIF
|
ES |
|
Nuvectis Pharma Inc
NASDAQ:NVCT
|
US |
|
Ichinen Holdings Co Ltd
TSE:9619
|
JP |
|
Sino Land Co Ltd
HKEX:83
|
HK |
|
Tharisa PLC
LSE:THS
|
CY |
|
Grid Metals Corp
XTSX:GRDM
|
CA |
|
B
|
BSL Ltd
BSE:514045
|
IN |
|
I
|
International Consolidated Airlines Group SA
F:INRA
|
UK |
|
Dynacor Gold Mines Inc
TSX:DNG
|
CA |
|
Vulcan Minerals Inc
XTSX:VUL
|
CA |
|
B
|
Buxly Paints Ltd
KAR:BUXL
|
PK |
|
Q
|
Qualys Inc
SWB:3L7A
|
US |
|
C
|
Cleghorn Minerals Ltd
OTC:CLGMF
|
CA |
|
DXP Enterprises Inc
NASDAQ:DXPE
|
US |
|
T
|
TechWing Inc
KOSDAQ:089030
|
KR |
|
Finseta PLC
LSE:FIN
|
UK |
|
Predator Oil & Gas Holdings PLC
LSE:PRD
|
JE |
|
Great Portland Estates PLC
OTC:GPEAF
|
UK |
Bankruptcy Probability
Silence Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Silence Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Silence Therapeutics PLC
OTC:SLNCF
|
902.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
513.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
62.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Silence Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Silence Therapeutics PLC has no debt.
You can find a full breakdown on its Balance Sheet.